Tygh Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
CCA
Tygh Capital Management's RGEN Position: Q2 2021 in Review
Tygh Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 24,796 shares — an estimated $4.82M sold.
Tygh Capital Management first reported a position in RGEN in Q2 2018 and held it in 12 quarters. The position peaked at $13M in Q2 2019. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.
- Tygh Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
- Tygh Capital Management sold 24,796 Repligen shares in Q2 2021, an estimated $4.82M.
- Tygh Capital Management first reported a position in Repligen in Q2 2018 and held it in 12 quarters.
- Tygh Capital Management's Repligen position peaked at $13M in Q2 2019.
- 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.
Based on Tygh Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.